AIM
AIA Investment Management Portfolio holdings
AUM
$437M
This Quarter Return
+33.59%
1 Year Return
+45.11%
3 Year Return
+42.46%
5 Year Return
–
10 Year Return
–
AUM
$441M
AUM Growth
+$441M
(-8.8%)
Cap. Flow
-$149M
Cap. Flow
% of AUM
-33.67%
Top 10 Holdings %
Top 10 Hldgs %
58.66%
Holding
472
New
65
Increased
92
Reduced
122
Closed
62
Top Buys
| 1 |
Pinduoduo
PDD
|
$7.8M |
| 2 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
$6.26M |
| 3 |
BZUN
Baozun
BZUN
|
$5.63M |
| 4 |
Trip.com Group
TCOM
|
$4.96M |
| 5 |
Workday
WDAY
|
$1.94M |
Top Sells
| 1 |
Alibaba
BABA
|
$162M |
| 2 |
JD.com
JD
|
$7.57M |
| 3 |
Baidu
BIDU
|
$5.34M |
| 4 |
GDS Holdings
GDS
|
$4.83M |
| 5 |
Meta Platforms (Facebook)
META
|
$1.48M |
Sector Composition
| 1 | Consumer Discretionary | 31.61% |
| 2 | Consumer Staples | 11.15% |
| 3 | Technology | 10.73% |
| 4 | Communication Services | 10.57% |
| 5 | Healthcare | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Amcor
AMCR
$19.4B
| $21K | ﹤0.01% |
2,063
-2,146
| -51% | -$21.8K |
|
327
Ball Corp
BALL
$13.9B
| $21K | ﹤0.01% |
304
-605
| -67% | -$41.8K |
|
328
Conagra Brands
CAG
$8.99B
| $21K | ﹤0.01% |
+609
| New | +$21K |
|
329
Cencora
COR
$57.2B
| $21K | ﹤0.01% |
+207
| New | +$21K |
|
330
Dynatrace
DT
$15.2B
| $21K | ﹤0.01% |
+522
| New | +$21K |
|
331
Elevance Health
ELV
$72.6B
| $21K | ﹤0.01% |
80
| – | – |
|
332
M&T Bank
MTB
$31.1B
| $21K | ﹤0.01% |
203
| – | – |
|
333
Qorvo
QRVO
$8.37B
| $21K | ﹤0.01% |
+190
| New | +$21K |
|
334
Sarepta Therapeutics
SRPT
$1.77B
| $21K | ﹤0.01% |
+128
| New | +$21K |
|
335
Wells Fargo
WFC
$262B
| $21K | ﹤0.01% |
819
+607
| +286% | +$15.6K |
|
336
Whirlpool
WHR
$5.06B
| $21K | ﹤0.01% |
+161
| New | +$21K |
|
|
CTLT
337
DELISTED
CATALENT, INC.
CTLT
| $21K | ﹤0.01% |
+290
| New | +$21K |
|
|
DRE
338
DELISTED
Duke Realty Corp.
DRE
| $21K | ﹤0.01% |
594
| – | – |
|
|
AMTD
339
DELISTED
TD Ameritrade Holding Corp
AMTD
| $21K | ﹤0.01% |
585
| – | – |
|
340
Cable One
CABO
$891M
| $20K | ﹤0.01% |
+11
| New | +$20K |
|
341
CBRE Group
CBRE
$47.5B
| $20K | ﹤0.01% |
439
-479
| -52% | -$21.8K |
|
342
DaVita
DVA
$9.79B
| $20K | ﹤0.01% |
+251
| New | +$20K |
|
343
Nasdaq
NDAQ
$53.7B
| $20K | ﹤0.01% |
+167
| New | +$20K |
|
344
Rogers Communications
RCI
$19.2B
| $20K | ﹤0.01% |
489
| – | – |
|
345
Zillow
Z
$19.8B
| $20K | ﹤0.01% |
+342
| New | +$20K |
|
346
Bio-Rad Laboratories Class A
BIO
$7.87B
| $19K | ﹤0.01% |
+41
| New | +$19K |
|
347
FMC
FMC
$4.81B
| $19K | ﹤0.01% |
189
| – | – |
|
348
Neurocrine Biosciences
NBIX
$14.1B
| $19K | ﹤0.01% |
+155
| New | +$19K |
|
349
Qiagen
QGEN
$10.2B
| $19K | ﹤0.01% |
+451
| New | +$19K |
|
350
UDR
UDR
$12.7B
| $19K | ﹤0.01% |
516
-849
| -62% | -$31.3K |
|